Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta 1*0101-and HLA-DRbeta 1*0401-restricted epitope from p53

Rojas, J.M., McArdle, S.E.B. ORCID: 0000-0001-6929-9782, Horton, R.B.V., Bell, M., Mian, S., Li, G., Ali, S.A. and Rees, R.C. ORCID: 0000-0002-4574-4746, 2005. Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta 1*0101-and HLA-DRbeta 1*0401-restricted epitope from p53. Cancer Immunology Immunotherapy, 54 (3), pp. 243-253. ISSN 0340-7004

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Cancer Immunology Immunotherapy
Creators:	Rojas, J.M., McArdle, S.E.B., Horton, R.B.V., Bell, M., Mian, S., Li, G., Ali, S.A. and Rees, R.C.
Publisher:	Springer
Place of Publication:	New York
Date:	2005
Volume:	54
Number:	3
ISSN:	0340-7004
Identifiers:	Number Type 10.1007/s00262-004-0596-7 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 09:44
Last Modified:	24 Nov 2021 15:01
URI:	https://irep.ntu.ac.uk/id/eprint/1918

Actions (login required)

Edit View

Views

Downloads